Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

“…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …”

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). by Ping-yu Cai (12389929)

Percentage survival of <i>Acinetobacter baumannii</i> infected <i>Galleria mellonella.</i> by Techit Thavorasak (13138440)

Related to Fig 3. by Mohammad Nafees Ansari (22232505)

“…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX^OE (mean ± SEM, <i>n</i> = 5) than BT-474_VECT^OE tumors. …”

IFA did not affect LPS-induced inflammation response. by Tingting Wang (123983)

IFA treatment facilitated host immune clearance of hypervirulent <i>K</i>. <i>pneumoniae</i> by targeting capsule. by Tingting Wang (123983)

IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. by Tingting Wang (123983)

IFA reduced the virulence of hypervirulent <i>K</i>. <i>pneumoniae</i> in <i>G</i>. <i>mellonella</i> larvae. by Tingting Wang (123983)

The effect of IFN-β and Vit D on the IL-1β expression. by Farzad Nasri (8941850)

“…In the co-treatment groups, a significant dose-dependent decrease was seen in the IL-1β expression <b>(C)</b>. …”

IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. by Tingting Wang (123983)

IFA disarmed capsule-mediated immune evasion. by Tingting Wang (123983)

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. by Tingting Wang (123983)

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. by Tingting Wang (123983)

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. by Tingting Wang (123983)

The effect of IFN-β and Vit D on the NF-κB gene expression. by Farzad Nasri (8941850)

“…Two lower concentrations of Vit D induced a reduction in the NF-κB expression compared to the control, while the highest concentration increased it significantly <b>(B)</b>. In the co-treatment groups, a dose-dependent decrease pattern among different concentration was seen in the NF-κB expression, but generally it was increased compared to the control <b>(C)</b>. …”

RICTOR regulates UGCG expression via transcription factor Zinc Finger X-linked (ZFX). by Mohammad Nafees Ansari (22232505)

“…<b>(T)</b> Tumor growth kinetics recorded a significantly higher growth of MCF-7_ZFX^OE (mean ± SEM, <i>n</i> = 4-6) than MCF-7_VECT^OE tumors. …”

Predictors in ordinal regression model for GDS. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

Classification of hand grip strength. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”